| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| George Matthew Spencer | Chief Executive Officer, Director | C/O MERLIN, INC., 129 SOUTH STREET, BOSTON | /s/ Leslie Renee Ravestein, Attorney-in-Fact | 18 Mar 2026 | 0002117604 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BACQ | Common Stock | Award | +14,890,622 | 14,890,622 | 16 Mar 2026 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BACQ | Stock Option | Award | +1,512,485 | 1,512,485 | 16 Mar 2026 | Common Stock | 1,512,485 | $8.48 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Represents securities received as part of the Issuer's business combination, in connection with the Business Combination Agreement, dated as of August 13, 2025, by and among the Issuer (formerly known as Inflection Point Acquisition Corp. IV), IPDX Merger Sub, Inc., a direct wholly owned subsidiary of the Issuer, and Merlin Labs, Inc. ("Legacy Merlin"), pursuant to which the common stock of Legacy Merlin automatically converted into newly issued shares of Common Stock. In addition, each Legacy Merlin stock option was automatically converted into the right to receive stock options of the Issuer with the same terms and conditions. |
| F2 | The stock option will vest in full on February 4, 2027. |